Effects of dopamine and other catecholamines on the splanchnic circulation.
D000818:Animals; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D002395:Catecholamines / Q000494:pharmacology*; D003864:Depression, Chemical; D004285:Dogs; D004298:Dopamine / Q000494:pharmacology; D018492:Dopamine Antagonists; D005260:Female; D006220:Haloperidol / Q000494:pharmacology; D006499:Hepatic Artery / Q000187:drug effects*; D007700:Kinetics; D008297:Male; D008638:Mesenteric Arteries / Q000187:drug effects*; D009638:Norepinephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D014662:Vasoconstrictor Agents / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology; D014690:Venous Pressure / Q000187:drug effects
D002395:Catecholamines; D018492:Dopamine Antagonists; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D010643:Phenoxybenzamine; D011433:Propranolol; D006220:Haloperidol; D004298:Dopamine; D009638:Norepinephrine